The Cortical Electrode Market includes a broad range of technologies designed to record or interface with electrical activity in the cerebral cortex. WiseGuyReports estimates that the global market will increase from USD 2 billion in 2025 to USD 4 billion by 2035, growing at a CAGR of 7.1%.

The market is segmented according to application, product type, end use, technology, and geographical region. Application categories include neuroprosthetics, brain mapping, seizure monitoring, and research applications. By type, the industry includes surface electrodes, intracortical electrodes, and flexible electrodes. Active, passive, and hybrid electrode technologies represent important technology segments.

Hospitals are major end users because of the growing use of cortical electrodes in neurological diagnosis, monitoring, and specialized procedures. Research institutions and rehabilitation centers also contribute significantly to demand as neural technologies continue to develop.

The competitive environment includes companies such as Boston Scientific, Blackrock Neurotech, Abbott Laboratories, NeuroPace, Medtronic, W. L. Gore & Associates, Cortical Dynamics, Neuralynx, Neuroelectrics, and other industry participants.

North America is expected to remain a dominant regional market, supported by advanced medical technology and strong research investment. Europe is also expanding steadily, while Asia-Pacific offers significant growth potential due to increasing healthcare expenditure and technological development.

As competition increases, companies are expected to focus on product innovation, improved electrode performance, strategic partnerships, AI integration, and expansion into emerging markets.